Tear Biomarkers and Alzheimer’s Disease
International Journal of Molecular Sciences · 30.08.2023 · 24 (17) · 13429
DOI: 10.3390/ijms241713429 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.08.2023. Verfasst von Snježana Kaštelan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Clinical Hospital Dubrava, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is an age-related progressive neurodegenerative brain disorder that represents the most common type of dementia. It poses a significant diagnostic challenge that requires timely recognition and treatment. Currently, there is no effective therapy for AD; however, certain medications may slow down its progression. The discovery of AD biomarkers, namely, magnetic resonance imaging, positron emission tomography and cerebrospinal fluid molecules (amyloid-β and tau) has advanced our understanding of this disease and has been crucial for identifying early neuropathologic changes prior to clinical changes and cognitive decline. The close interrelationship between the eye and the brain suggests that tears could be an interesting source of biomarkers for AD; however, studies in this area are limited. The identification of biomarkers in tears will enable the development of cost-effective, non-invasive methods of screening, diagnosis and disease monitoring. In order to use tears as a standard method for early and non-invasive diagnosis of AD, future studies need to be conducted on a larger scale.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Clinical Hospital Dubrava, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
- Centre for Palliative Medicine, Medical Ethics and Communication Skills, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
- Department of Medical Statistics, Epidemiology and Medical Informatics, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
- Department of Integrative Psychiatry, Psychiatry Hospital "Sveti Ivan", 10090 Zagreb, Croatia.
- Health Centre of the Croatian Department of Internal Affairs, 10000 Zagreb, Croatia.
- Department of Family Medicine, Health Centre Zagreb-Centar, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
ORCID-Profile: Snježana Kaštelan, Neda Pjevač, Nada Pjevač Keleminić, Antonela Gverović Antunica
Zitieren
APA
Kaštelan, S., Braš, M., Pjevač, N., Bakija, I., Tomić, Z., Pjevač Keleminić, N., & Gverović Antunica, A. (2023). Tear Biomarkers and Alzheimer’s Disease. International Journal of Molecular Sciences, 24(17), 13429. https://doi.org/10.3390/ijms241713429
Vancouver
Kaštelan S, Braš M, Pjevač N, Bakija I, Tomić Z, Pjevač Keleminić N, et al. Tear Biomarkers and Alzheimer’s Disease. International Journal of Molecular Sciences. 2023;24(17):13429. doi:10.3390/ijms241713429
BibTeX
@article{Katelan2023,
author = {Kaštelan, Snježana and Braš, Marijana and Pjevač, Neda and Bakija, Ivana and Tomić, Zora and Pjevač Keleminić, Nada and Gverović Antunica, Antonela},
title = {Tear Biomarkers and Alzheimer’s Disease},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {17},
pages = {13429},
doi = {10.3390/ijms241713429}
}
EUVIMED